科兴制药
(688136)
| 流通市值：33.76亿 | | | 总市值：33.76亿 |
| 流通股本：1.99亿 | | | 总股本：1.99亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 353,786,568.63 | 568,796,215.77 | 330,631,876.64 | 541,515,834.34 |
| 应收票据及应收账款 | 353,753,201.45 | 285,719,518.7 | 364,626,899.05 | 367,696,921.89 |
| 其中：应收票据 | 11,818,427.9 | 11,196,633.54 | 37,974,999.76 | 42,747,758.36 |
| 应收账款 | 341,934,773.55 | 274,522,885.16 | 326,651,899.29 | 324,949,163.53 |
| 应收款项融资 | 47,149,777.87 | 56,322,009.29 | 44,760,620.76 | 37,464,353.82 |
| 预付款项 | 32,577,638.66 | 24,925,027.45 | 19,840,989.19 | 16,832,536.63 |
| 其他应收款合计 | 4,785,892.2 | 4,450,543.84 | 4,583,559.56 | 4,297,947.35 |
| 存货 | 178,305,618.67 | 191,364,918.26 | 170,266,219.68 | 175,331,251.65 |
| 一年内到期的非流动资产 | - | - | 1,228,744.1 | 2,139,881.12 |
| 其他流动资产 | 1,885,497.45 | 2,045,983.79 | 1,923,943.89 | 3,233,981.09 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,160,746,557.13 | 1,133,624,217.1 | 1,219,837,072.05 | 1,317,082,985.67 |
| 非流动资产: | | | | |
| 长期股权投资 | 4,016,956.81 | 4,023,438.04 | - | - |
| 其他权益工具投资 | 15,000,000 | 15,000,000 | 15,000,000 | 15,000,000 |
| 其他非流动金融资产 | 226,296,683.92 | 226,296,683.92 | 249,022,819.68 | 263,030,673.04 |
| 投资性房地产 | 21,588,195.75 | 21,932,693.1 | 22,259,804.79 | 22,586,916.43 |
| 固定资产 | 933,578,508.87 | 804,691,512.56 | 795,925,219.12 | 768,749,956.74 |
| 在建工程 | 253,382,505.11 | 372,557,740.5 | 362,509,532.1 | 376,164,719.09 |
| 使用权资产 | 35,122,433.77 | 22,511,635.37 | 28,176,138.04 | 31,638,879.16 |
| 无形资产 | 155,162,388.18 | 158,722,821.56 | 161,950,789.23 | 162,520,139.28 |
| 开发支出 | - | - | 118,074,703.06 | 70,408,895.27 |
| 长期待摊费用 | 1,440,716.1 | 3,077,779.38 | 5,903,818.21 | 8,674,435.41 |
| 递延所得税资产 | 131,431,433.48 | 133,976,133.48 | 88,281,433.51 | 92,308,743.01 |
| 其他非流动资产 | 126,104,170.69 | 134,678,435.29 | 109,987,105.78 | 102,406,324.9 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,903,123,992.68 | 1,897,468,873.2 | 1,957,091,363.52 | 1,913,489,682.33 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,063,870,549.81 | 3,031,093,090.3 | 3,176,928,435.57 | 3,230,572,668 |
| 流动负债: | | | | |
| 短期借款 | 120,841,210 | 120,702,611 | 144,020,821 | 168,020,821 |
| 应付票据及应付账款 | 171,975,986.16 | 193,462,268.29 | 200,180,183.39 | 171,618,655.96 |
| 应付账款 | 171,975,986.16 | 193,462,268.29 | 200,180,183.39 | 171,618,655.96 |
| 预收款项 | 521,428.57 | 799,740.07 | 579,365.31 | 1,133,073.13 |
| 合同负债 | 6,982,559.82 | 19,635,736.26 | 5,532,320.14 | 9,067,123.36 |
| 应付职工薪酬 | 22,979,668.3 | 24,600,338.65 | 13,641,802.5 | 16,469,807.72 |
| 应交税费 | 4,653,498.6 | 4,156,444.1 | 10,156,592.08 | 8,751,161.26 |
| 其他应付款合计 | 20,320,674.12 | 21,049,086.94 | 18,217,594.4 | 19,586,101.9 |
| 一年内到期的非流动负债 | 417,148,056.28 | 281,732,100.32 | 306,759,656.55 | 126,917,676.22 |
| 其他流动负债 | 1,218,109.31 | 3,856,537.68 | 5,487,019.37 | 9,095,798.92 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 766,641,191.16 | 669,994,863.31 | 704,575,354.74 | 530,660,219.47 |
| 非流动负债: | | | | |
| 长期借款 | 633,494,753.16 | 695,839,614.6 | 667,126,129.59 | 886,460,251.97 |
| 租赁负债 | 21,550,297.89 | 17,785,554.54 | 20,274,108.42 | 21,048,991.67 |
| 递延收益 | 5,055,103.71 | 5,321,803.28 | 2,050,924.66 | 2,144,042.41 |
| 递延所得税负债 | 13,257,650.06 | 11,356,160.87 | 15,591,668.23 | 16,302,438.93 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 673,357,804.82 | 730,303,133.29 | 705,042,830.9 | 925,955,724.98 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,439,998,995.98 | 1,400,297,996.6 | 1,409,618,185.64 | 1,456,615,944.45 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 199,198,650 | 199,198,650 | 199,198,650 | 199,198,650 |
| 资本公积 | 1,282,723,004.76 | 1,281,524,299.59 | 1,280,674,724.77 | 1,279,115,668.77 |
| 减:库存股 | 19,997,306.38 | - | - | - |
| 其他综合收益 | 380,544.26 | -6,259.8 | - | - |
| 盈余公积 | 19,852,419.09 | 19,852,419.09 | 19,852,419.09 | 19,852,419.09 |
| 未分配利润 | 137,854,972.62 | 125,451,529.17 | 261,427,063.25 | 268,180,348.82 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,620,012,284.35 | 1,626,020,638.05 | 1,761,152,857.11 | 1,766,347,086.68 |
| 少数股东权益 | 3,859,269.48 | 4,774,455.65 | 6,157,392.82 | 7,609,636.87 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,623,871,553.83 | 1,630,795,093.7 | 1,767,310,249.93 | 1,773,956,723.55 |
| 负债和股东权益合计 | 3,063,870,549.81 | 3,031,093,090.3 | 3,176,928,435.57 | 3,230,572,668 |
| 公告日期 | 2024-04-27 | 2024-04-27 | 2023-10-28 | 2023-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |